Here are Monday's biggest analyst calls: Nvidia, SpaceX, Apple, Oracle, AMD, Bullish, Meta, Rollins & more

Wall Street analysts issued a broadly constructive batch of recommendations, including upgrades for Rollins, SAP, AMD and Unum, plus bullish initiations or reiterations across AI, biotech, defense and digital assets. JPMorgan raised Unum to Overweight but cut its price target from $98 to $90; it also downgraded Molson Coors to Underweight after 3Q26 earnings. Initiation targets included $22 for Iambic by December 2027, $42 for Bullish and $47 for Supernus; no share-price reactions were reported.

Analysis

This is a dispersion signal, not a broad risk-on signal: the most investable distinction is between AI claims with a near-term monetization path and those resting on longer-dated capacity or product optionality. Meta’s ad tooling has the clearest route to measurable results; watch ad pricing and impressions in the next 1–3 months, while Muse and enterprise APIs remain longer-horizon upside rather than underwriteable earnings today. SAP’s systems-of-record positioning may help defend its relevance as AI moves into production, but the thesis needs evidence in cloud growth, backlog conversion, and AI-related customer spending—not just improving product claims.

Near term, analyst upgrades and reiterations can support sentiment, but they are weak evidence of incremental estimates. Apple delivery availability is ambiguous between robust demand and constrained supply; without sell-through or supply data, it is not a directional signal. Likewise, bullish management meetings on AMD and buy-the-dip calls on Oracle do not establish returns on AI investment. On Rollins, continued acquisition activity at high industry multiples can expand reach but raises integration and purchase-price risk. The RV calls themselves acknowledge affordability and demand constraints: diversification or self-help may cushion, not remove, cyclicality.

Over 6–18 months, defense-oriented manufacturing and AI drug discovery could benefit from structural demand, but the roundup supplies no order, revenue, or cash-burn evidence to size those theses. The key contrarian point: repeated bullish calls may be more useful as a catalyst calendar than as fresh fundamental information. Prefer measurable monetization and balance-sheet resilience; avoid treating thematic exposure as proof of earnings conversion.

Key Decisions for Investors

• Favor a staged long in META on weakness rather than chasing the analyst-list attention. Reassess after the next report: sustained ad revenue growth and improving monetization metrics support the thesis; slowing ad trends or rising AI spend without revenue contribution falsify it.
• Keep SAP on a 1–3 month watchlist, not an automatic upgrade-following buy. Add only if reported cloud/backlog conversion or customer evidence validates production AI demand; otherwise the systems-of-record argument may already be reflected in expectations.
• Maintain an underweight/watch stance on TAP versus stronger, measurable growth exposures. The downgrade is directionally consistent with risk, but confirm with volume, mix, and forward guidance before initiating a short; stabilization in those metrics would invalidate the setup.
• Do not trade AAPL, AMD, NVDA, or ORCL solely on these broker comments. For AAPL, verify sell-through versus supply constraints; for AMD/ORCL, look for estimate revisions and evidence of AI investment returns. Revisit the semiconductor/AI infrastructure exposure if demand or customer spending guidance weakens.